|
Volumn 35, Issue 5 SUPPL., 2011, Pages
|
Issues involved in the process of developing a medical food
|
Author keywords
Enteral formula; Medical food; Obesity; Pharmaconutrition
|
Indexed keywords
OMEGA 3 FATTY ACID;
DRUG;
ARTICLE;
CALORIC INTAKE;
CRITICALLY ILL PATIENT;
DIET THERAPY;
DISEASE PREDISPOSITION;
ENERGY EXPENDITURE;
ENTERIC FEEDING;
FOOD;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
INTENSIVE CARE UNIT;
MALNUTRITION;
MEDICAL EDUCATION;
NUTRITION;
OBESITY;
PARENTERAL NUTRITION;
PATIENT SAFETY;
PHASE 3 CLINICAL TRIAL (TOPIC);
PHASE 4 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
UNITED STATES;
BIOAVAILABILITY;
COMMERCIAL PHENOMENA;
DRUG INDUSTRY;
DRUG LABELING;
METHODOLOGY;
PRODUCT SAFETY;
STANDARD;
BIOLOGICAL AVAILABILITY;
COMMERCE;
CONSUMER PRODUCT SAFETY;
DRUG INDUSTRY;
DRUG LABELING;
ENTERAL NUTRITION;
FOOD;
HUMANS;
OBESITY;
PHARMACEUTICAL PREPARATIONS;
|
EID: 84855398092
PISSN: 01486071
EISSN: None
Source Type: Journal
DOI: 10.1177/0148607111415281 Document Type: Article |
Times cited : (3)
|
References (9)
|